Wellspring Biosciences Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $440K
Latest Deal Amount
  • Investors
  • 1

Wellspring Biosciences General Information

Description

Developer of small molecule drugs intended for the treatment of cancer and other diseases. The company specializes in translating chemical and biological insights into novel, highly targeted drugs that are cell active and mutant specific, thereby enabling patients to have access to unique and potent drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3033 Science Park Drive
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Wellspring Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2014 $440K Completed Startup
4. Merger/Acquisition 01-Jan-2013 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Early Stage VC (Series A) Completed Startup
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view Wellspring Biosciences’s complete valuation and funding history, request access »

Wellspring Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small molecule drugs intended for the treatment of cancer and other diseases. The company specializes in tr
Drug Discovery
San Diego, CA
5 As of 2017
0000000000

00000-00

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000 000000000
Brussels, Belgium
0 As of 0000
000.00
00000000000 000.00

0000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000000000000
Dublin, OH
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Wellspring Biosciences Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Camel-IDS Venture Capital-Backed Brussels, Belgium 0 000.00 00000000000 000.00
0000000 0000000000 Corporation Dublin, OH 00 000.00 000000000 000.00
To view Wellspring Biosciences’s complete competitors history, request access »

Wellspring Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Kevan Shokat Co-Founder & Chairman Of Scientific Advisory Board
Frank McCormick Ph.D Co-Founder
Yi Liu Ph.D Co-Founder & Chief Scientific Officer
Troy Wilson Ph.D Executive Chairman
To view Wellspring Biosciences’s complete executive team members history, request access »

Wellspring Biosciences Board Members (2)

Name Representing Role Since
Kevan Shokat Wellspring Biosciences Co-Founder & Chairman Of Scientific Advisory Board 000 0000
Troy Wilson Ph.D Self Executive Chairman 000 0000
To view Wellspring Biosciences’s complete board members history, request access »

Wellspring Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wellspring Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Wellspring Biosciences’s complete investors history, request access »